SCHEMBL17876008

SCHEMBL17876008

O=S1(=O)Cc2ccc(-c3cc(-c4ccccc4)nc(-c4ccccc4)c3)cc2-c2cc(-c3cccc4oc5ccccc5c34)ccc2C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 1/20 0.33
KDM4E B2RXH2 4/20 0.32
PLA2G2A P14555 3/20 0.32
PLA2G4A P47712 3/20 0.32
HPGD P15428 3/20 0.32
ALDH1A1 P00352 2/20 0.32
MAPT P10636 2/20 0.32
MAPK1 P28482 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
PLA2G10 O15496 1/20 0.32
DHODH Q02127 1/20 0.32
PRKDC P78527 1/20 0.32
PLAUR Q03405 1/20 0.31
ACACA Q13085 1/20 0.31
ALOX5 P09917 1/20 0.31
SMN1; SMN2 Q16637 3/20 0.31
LMNA P02545 2/20 0.31
PDE10A Q9Y233 1/20 0.31
PIM1 P11309 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17875971 0.96 PRKDC (0.32) BACE1KDM4EPLA2G2APLA2G4AHPGD
SCHEMBL17875956 0.96 PRKDC (0.32) BACE1KDM4EPLA2G2APLA2G4AHPGD
SCHEMBL17876004 0.90 PLA2G2A (0.40) BACE1PLA2G2APLA2G4AHPGDALDH1A1
SCHEMBL17875992 0.89 ALOX5 (0.45) PRKDCALOX5PIM1CSNK2A2CSNK2B
SCHEMBL17876006 0.88 PLA2G2A (0.38) KDM4EPLA2G2APLA2G4AHPGDALDH1A1
SCHEMBL17875996 0.88 HCRTR1 (0.37) KDM4EPLA2G2APLA2G4AHPGDALDH1A1
SCHEMBL17876005 0.88 ALOX5 (0.38) BACE1KDM4EPLA2G2APLA2G4AHPGD
SCHEMBL17875958 0.86 PLA2G2A (0.37) PLA2G2APLA2G4AHPGDMAPTL3MBTL1
SCHEMBL17875952 0.86 PLA2G2A (0.37) PLA2G2APLA2G4AHPGDMAPTL3MBTL1
SCHEMBL17875909 0.86 HSP90AA1 (0.38) BACE1KDM4EPLA2G2APLA2G4AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 BACE1 709/4885KDM4E 3120/4885PLA2G2A 4359/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 BACE1 709/4885KDM4E 3120/4885PLA2G2A 4359/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.